The IMDRF comprises of medical device regulators from around the world who have come together to accelerate international medical device regulatory harmonisation and convergence.
International harmonisation provides an important basis for reducing regulatory effort for both authorities and companies and for exploiting synergies through regulatory cooperation.
At Swissmedic's request, the IMDRF granted the Swiss Agency for Therapeutic Products the status of Official Observer at Management Committee Meetings. This new status is an important interim step towards Swissmedic's strategic objective of being admitted as a member of the Management Committee.
Swissmedic experts have already been directly and actively involved in various working groups since 2021.